• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观扩散系数指标在鉴别胶质母细胞瘤患者治疗后与治疗相关异常及肿瘤进展中的应用:一项回顾性研究

Apparent Diffusion Coefficient Metrics to Differentiate between Treatment-Related Abnormalities and Tumor Progression in Post-Treatment Glioblastoma Patients: A Retrospective Study.

作者信息

van den Elshout Rik, Herings Siem D A, Mannil Manoj, Gijtenbeek Anja M M, Ter Laan Mark, Smeenk Robert J, Meijer Frederick J A, Scheenen Tom W J, Henssen Dylan J H A

机构信息

Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Radiologie Radboudumc, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.

出版信息

Cancers (Basel). 2023 Oct 14;15(20):4990. doi: 10.3390/cancers15204990.

DOI:10.3390/cancers15204990
PMID:37894355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10605800/
Abstract

Distinguishing treatment-related abnormalities (TRA) from tumor progression (TP) in glioblastoma patients is a diagnostic imaging challenge due to the identical morphology of conventional MR imaging sequences. Diffusion-weighted imaging (DWI) and its derived images of the apparent diffusion coefficient (ADC) have been suggested as diagnostic tools for this problem. The aim of this study is to determine the diagnostic accuracy of different cut-off values of the ADC to differentiate between TP and TRA. In total, 76 post-treatment glioblastoma patients with new contrast-enhancing lesions were selected. Lesions were segmented using a T1-weighted, contrast-enhanced scan. The mean ADC values of the segmentations were compared between TRA and TP groups. Diagnostic accuracy was compared by use of the area under the curve (AUC) and the derived sensitivity and specificity values from cutoff points. Although ADC values in TP (mean = 1.32 × 10 mm/s; SD = 0.31 × 10 mm/s) were significantly different compared to TRA (mean = 1.53 × 10 mm/s; SD = 0.28 × 10 mm/s) ( = 0.003), considerable overlap in their distributions exists. The AUC of ADC values to distinguish TP from TRA was 0.71, with a sensitivity and specificity of 65% and 70%, respectively, at an ADC value of 1.47 × 10 mm/s. These findings therefore indicate that ADC maps should not be used in discerning between TP and TRA at a certain timepoint without information on temporal evolution.

摘要

在胶质母细胞瘤患者中,由于传统磁共振成像序列形态相同,区分与治疗相关的异常(TRA)和肿瘤进展(TP)是一项诊断成像挑战。扩散加权成像(DWI)及其表观扩散系数(ADC)衍生图像已被建议作为解决此问题的诊断工具。本研究的目的是确定不同ADC截止值区分TP和TRA的诊断准确性。总共选择了76例治疗后出现新的对比增强病变的胶质母细胞瘤患者。使用T1加权对比增强扫描对病变进行分割。比较TRA组和TP组分割区域的平均ADC值。通过曲线下面积(AUC)以及截止点得出的敏感性和特异性值比较诊断准确性。尽管TP组的ADC值(平均值 = 1.32×10⁻³mm²/s;标准差 = 0.31×10⁻³mm²/s)与TRA组(平均值 = 1.53×10⁻³mm²/s;标准差 = 0.28×10⁻³mm²/s)相比有显著差异(P = 0.003),但其分布存在相当大的重叠。区分TP和TRA的ADC值的AUC为0.71,在ADC值为1.47×10⁻³mm²/s时,敏感性和特异性分别为65%和70%。因此,这些发现表明,在没有时间演变信息的情况下,在某个时间点,ADC图不应被用于区分TP和TRA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/096b/10605800/63bd4155b177/cancers-15-04990-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/096b/10605800/94ee55632754/cancers-15-04990-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/096b/10605800/63bd4155b177/cancers-15-04990-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/096b/10605800/94ee55632754/cancers-15-04990-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/096b/10605800/63bd4155b177/cancers-15-04990-g002.jpg

相似文献

1
Apparent Diffusion Coefficient Metrics to Differentiate between Treatment-Related Abnormalities and Tumor Progression in Post-Treatment Glioblastoma Patients: A Retrospective Study.表观扩散系数指标在鉴别胶质母细胞瘤患者治疗后与治疗相关异常及肿瘤进展中的应用:一项回顾性研究
Cancers (Basel). 2023 Oct 14;15(20):4990. doi: 10.3390/cancers15204990.
2
Diffusion imaging could aid to differentiate between glioma progression and treatment-related abnormalities: a meta-analysis.扩散成像有助于鉴别胶质瘤进展与治疗相关异常:一项荟萃分析。
Insights Imaging. 2022 Oct 4;13(1):158. doi: 10.1186/s13244-022-01295-4.
3
Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.淋巴瘤和胶质母细胞瘤:3T 高 b 值扩散加权磁共振成像评估表观扩散系数的差异。
Eur J Radiol. 2012 Feb;81(2):339-44. doi: 10.1016/j.ejrad.2010.11.005. Epub 2010 Dec 3.
4
Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.瘤周最小表观弥散系数对鉴别胶质母细胞瘤与单发转移瘤的诊断价值。
AJR Am J Roentgenol. 2011 Jan;196(1):71-6. doi: 10.2214/AJR.10.4752.
5
Diffusion-weighted magnetic resonance imaging without bowel preparation for detection of ulcerative colitis.无需肠道准备的扩散加权磁共振成像用于溃疡性结肠炎的检测
World J Gastroenterol. 2015 Sep 7;21(33):9785-92. doi: 10.3748/wjg.v21.i33.9785.
6
Added Value of Diffusion-Weighted Magnetic Resonance Imaging in Differentiating Musculoskeletal Tumors Using Sensitivity and Specificity: A Retrospective Study and Review of Literature.利用敏感性和特异性评估扩散加权磁共振成像在鉴别肌肉骨骼肿瘤中的附加价值:一项回顾性研究及文献综述
Cureus. 2021 Jan 1;13(1):e12422. doi: 10.7759/cureus.12422.
7
Comparison of conventional magnetic resonance imaging and diffusion-weighted imaging in the differentiation of bone plasmacytoma from bone metastasis in the extremities.常规磁共振成像与弥散加权成像在四肢骨浆细胞瘤与骨转移瘤鉴别诊断中的比较。
Diagn Interv Imaging. 2021 Oct;102(10):611-618. doi: 10.1016/j.diii.2021.05.009. Epub 2021 Jun 11.
8
Can diffusion-weighted imaging distinguish between benign and malignant pediatric liver tumors?扩散加权成像能否区分儿童肝脏良性和恶性肿瘤?
Pediatr Radiol. 2018 Jan;48(1):85-93. doi: 10.1007/s00247-017-3984-9. Epub 2017 Sep 18.
9
Distinguishing glioblastoma progression from treatment-related changes using DTI directionality growth analysis.使用扩散张量成像(DTI)方向性生长分析区分胶质母细胞瘤进展与治疗相关变化。
Neuroradiology. 2024 Dec;66(12):2143-2151. doi: 10.1007/s00234-024-03450-8. Epub 2024 Aug 17.
10
Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma.磁共振成像中表观扩散系数和增强率在鉴别原发性脑淋巴瘤与胶质母细胞瘤中的准确性
Neuroradiol J. 2019 Oct;32(5):328-334. doi: 10.1177/1971400919857556. Epub 2019 Jun 12.

引用本文的文献

1
Independent histological validation of MR-derived radio-pathomic maps of tumor cell density using image-guided biopsies in human brain tumors.利用人脑肿瘤的图像引导活检对基于磁共振成像的肿瘤细胞密度放射组学图谱进行独立组织学验证。
J Neurooncol. 2025 Jun 21. doi: 10.1007/s11060-025-05105-x.

本文引用的文献

1
The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas.2021 年世界卫生组织(WHO)脑肿瘤分类及其对影像诊断的影响:第五版要点——成人弥漫性胶质瘤的影像学表现概述。
J Magn Reson Imaging. 2023 Sep;58(3):677-689. doi: 10.1002/jmri.28743. Epub 2023 Apr 17.
2
Diffusion imaging could aid to differentiate between glioma progression and treatment-related abnormalities: a meta-analysis.扩散成像有助于鉴别胶质瘤进展与治疗相关异常:一项荟萃分析。
Insights Imaging. 2022 Oct 4;13(1):158. doi: 10.1186/s13244-022-01295-4.
3
Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression.
灌注磁共振成像在胶质瘤复发与假性进展鉴别诊断中的应用:一项系统评价、Meta分析及Meta回归分析
Quant Imaging Med Surg. 2022 Oct;12(10):4805-4822. doi: 10.21037/qims-22-32.
4
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma.在区分胶质母细胞瘤患者的假性进展和疾病进展方面,磁共振波谱比灌注成像表现更优。
Neurooncol Adv. 2022 Aug 15;4(1):vdac128. doi: 10.1093/noajnl/vdac128. eCollection 2022 Jan-Dec.
5
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation.新诊断为胶质母细胞瘤患者接受放化疗后“临床定义的假性进展”的发生率、分子特征和影像学特征。
J Neurooncol. 2022 Sep;159(3):509-518. doi: 10.1007/s11060-022-04088-3. Epub 2022 Jul 17.
6
MRI biomarkers in neuro-oncology.神经肿瘤学中的 MRI 生物标志物。
Nat Rev Neurol. 2021 Aug;17(8):486-500. doi: 10.1038/s41582-021-00510-y. Epub 2021 Jun 20.
7
Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.脑胶质瘤治疗后影像学表现:进展、假性进展、假性缓解、放射性坏死。
Neuroimaging Clin N Am. 2021 Feb;31(1):103-120. doi: 10.1016/j.nic.2020.09.010.
8
Efficiency of High and Standard Value Diffusion-Weighted Magnetic Resonance Imaging in Grading of Gliomas.高值与标准值扩散加权磁共振成像在胶质瘤分级中的效能
J Oncol. 2020 Sep 14;2020:6942406. doi: 10.1155/2020/6942406. eCollection 2020.
9
Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters.酰胺质子转移成像在鉴别复发性弥漫性神经胶质瘤与治疗后改变中的作用:对弥散和灌注参数的增量价值。
Neuroradiology. 2021 Mar;63(3):363-372. doi: 10.1007/s00234-020-02542-5. Epub 2020 Sep 2.
10
Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.基于表观扩散系数测量的扩散磁共振成像鉴别胶质瘤复发与假性进展诊断性能的Meta分析
Medicine (Baltimore). 2020 Jun 5;99(23):e20270. doi: 10.1097/MD.0000000000020270.